Gregory Gorgas
Net worth: 1 590 $ as of 31/05/2026
Net worth: 1 590 $ as of 31/05/2026
Gregory D.
Gorgas was the founder of Theragence, Inc., founded in 2009, where the title held was Managing Director from 2009 to 2011.
Current jobs include President, CEO, Secretary & Director at Artelo Biosciences, Inc. starting in 2025; Director at Klotho Therapeutics, Inc.; and Director at Theragence, Inc. Former jobs include Senior Director-Global & United States Marketing at Biogen, Inc. from 2006 to 2008; Senior Vice President-Commercial & Corporate at Mast Therapeutics, Inc. from 2011 to 2017; and Senior Vice President-Commercial at Savara, Inc. Education includes undergraduate studies at The California State University and an MBA from the University of Phoenix.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/02/2026 | 1,136 ( 0.05% ) | 1 590 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Chief Executive Officer | 03/04/2017 |
Klotho Therapeutics, Inc.
Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease | Director/Board Member | - |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Corporate Officer/Principal | 01/01/2017 |
| SAVARA INC. | Corporate Officer/Principal | 28/12/2016 |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Chief Executive Officer | 01/07/2011 |
| BIOGEN INC. | Sales & Marketing | 01/10/2008 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Health Technology |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Klotho Therapeutics, Inc.
Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions